StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly scope 2 indirect GHG emissions — Market-based (metric tonnes CO2e)

Lilly Sustainability Reports (2022–2025)

Latest, FY2025
208,000
Period ended Dec 31, 2025
Change on a year earlier
-19.4%
258,000 in FY2024
History
6 years
Since FY2020
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScope 2 indirect GHG emissions — Market-based (metric tonnes CO2e)Year on yearSource
FY2025Dec 31, 2025208,000-19.4%Lilly 2025 Sustainability Highlights Report ↗
FY2024Dec 31, 2024258,000-25.2%Lilly 2024 Sustainability Report ↗
FY2023Dec 31, 2023345,000-7.8%Lilly 2024 Sustainability Report ↗
FY2022Dec 31, 2022374,000-19.7%Lilly 2024 Sustainability Report ↗
FY2021Dec 31, 2021466,000-15.4%Lilly 2024 Sustainability Report ↗
FY2020Dec 31, 2020551,000–Lilly 2024 Sustainability Report ↗

Cite this data

StockData. (2026). Eli Lilly Scope 2 indirect GHG emissions — Market-based (metric tonnes CO2e), annual FY2020–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/esg_scope2_mkt_ghg

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.